Rhon-klinikum Ag · XETR:RHK
Rhon-klinikum — Q1 2018 Earnings Presentation
12 slides from Rhon-klinikum's earnings presentation, May 4, 2018
Slide 1: First Quarter 2018 Results
First Quarter 2018 Results 4 May 2018 RHÖN-KLINIKUM AG - First Quarter 2017 Results - as of May 5, 2017 1
Slide 2: Disclaimer
Disclaimer This document has been prepared by RHÖN-KLINIKUM AG (“RHÖN-KLINIKUM” or “the Company”) for information purposes only, solely for use during this presentation. It must be treated confidentially by attendees at such presentation and must not be distributed, passed on or otherwise disclose
Slide 3: Highlights Q1 2018
Highlights Q1 2018 Dynamic and good start to 2018. Volume growth within anticipated range, disproportional rise of EBITDA and net profit Revenues +3.9%/EBITDA + 8.2%/Net Profit + 23.8% 216,602 total patient contacts (+2.1%) Important milestones of flagship “Campus Bad Neustadt” achieved In
Slide 4: Key P&L figures First quarter of 2018
Key P&L figures First quarter of 2018 SALES: Q1 with moderate growth of +2.5% after anticipated Performance* vs. Q1 2018 regulatory cutbacks and subtraction of adjustments... in € millions Q1 2017 o (-) 2.4% Spinraza effect Revenue 311.7 100.0% 3.9% o (+) 1.0% MDK corrections Personnel exp. -199.7 6
Slide 5: Core balance sheet positions as of March 2018
Core balance sheet positions as of 31 March 2018 €1,504m €1,504m 64.6 % €971m Non-current assets €1,135m 75.5 % Equity €20m cash €533m 35.4 % €25m Non-current liabilities 1.6 % Current assets €344m Current liabilities 22.9 % €199m cash Assets Equity & liabilities Sustainable and strong Cash (~ €21
Slide 6: AGM 2018 Dividend proposal
AGM 2018 Dividend proposal The management board and supervisory board will propose to the Annual General Meeting on 6 June 2018 the distribution of a dividend of € 0.22 per share (total dividend sum of € 14.7m based on 66.9m shares) “A dividend of € 0.22 per share corresponds to a payout ratio of ap
Slide 7: Management Board Composition and tasks as of May 2018
Management Board Composition and tasks as of 1 May 2018 Stephan Holzinger (CEO/CFO) Corporate communications, IR, corporate development, accounting, tax, controlling, corporate finance, HR, legal, data protection, compliance, internal audit, digital transformation and corporate offices Prof. Dr.
Slide 8: Outlook 2018 Guidance
Outlook 2018 Assumptions & key drivers Organic growth Other impacts Inflation on One-off effects +3.0% to 3.5% p.a. on Top Line input prices on EBITDA Average DRG prices “Spinraza” effect with Wages Separate accounting +2.7% approx. +€ 20m +2.0 % to 3.0% +€ 20m Average DRG volumes IFRS 1
Slide 9: Appendix Financial Calendar for FY 2018
Appendix Financial Calendar for FY 2018 23 February 2018 Preliminary results for financial year 2017 Conference call 29 March 2018 Publication of annual financial report 2017 Press conference 4 May 2018 Publication of interim report for the quarter ending 31 March 2018 6 June 2018 Annual Gen
Slide 10: Price Regulation in 2018 at a Glance
Appendix Price Regulation in 2018 at a Glance Average base rate increase in states with RHÖN hospitals Federal Total hospital system budget (weighted by RHÖN case mix) Level Wage sum increase as main reference number for RHÖN effective base rate Benchmark (wage sum) 1 DRG inflation in 2018: +2.97%
Slide 11: Shareholder base
Appendix Shareholder base Shareholder Structure as of 31 March 2018, according to the most recent notifications of voting rights at that time 25.1% Asklepios 26.7% 1) 29.9% Free Float 70.1% 3.2% Strategic Landeskrankenhilfe Investors 5.4% 25.0% 2) Ingeborg Münch B. Braun 14.6% Eugen Münch/HCM SE 1)
Slide 12: IR contact information
Appendix IR contact information Contact Julian Schmitt Head of Investor Relations tel +49 9771 65 1536 email ir@rhoen-klinikum-ag.com RHÖN-KLINIKUM AG - Appendix 12